Article info
PDFHeart failure and cardiomyopathies
Original research
Prognostic importance of the 6 min walk test in light chain (AL) amyloidosis
- Correspondence to Dr Ashutosh D Wechalekar, University College London (Royal Free Campus), National Amyloidosis Centre, London, NW3 2PF, UK; a.wechalekar{at}ucl.ac.uk
Citation
Prognostic importance of the 6 min walk test in light chain (AL) amyloidosis
Publication history
- Received December 17, 2021
- Accepted April 14, 2022
- First published June 28, 2022.
Online issue publication
September 26, 2022
Article Versions
- Previous version (28 June 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.